MYC-Induced Replicative Stress: A Double-Edged Sword for Cancer Development and Treatment

Area of Science:

• Molecular Biology
• Cancer Biology
• Genetics

Background:

• MYC is a key transcription factor regulating cell cycle, metabolism, and differentiation.
• Deregulation of MYC in tumors leads to widespread genomic binding and altered gene expression.
• MYC overexpression impacts cell cycle control, promoting premature S-phase entry and altering DNA replication.

Purpose of the Study:

• To review how MYC influences DNA and RNA synthesis.
• To discuss the evidence for MYC-induced replicative and transcriptional stress.
• To summarize preclinical data on targeting replicative stress in MYC-driven cancers.

Main Methods:

• Literature review of MYC's role in DNA/RNA synthesis.
• Analysis of studies on MYC-induced cellular stress.
• Summary of preclinical therapeutic strategies targeting replicative stress.

Main Results:

• MYC controls a significant portion of cellular genes involved in fundamental processes.
• MYC deregulation leads to genome-wide binding and selective gene expression changes.
• Altered cell cycle control and DNA replication landscape are characteristic of MYC-driven cancers.
• Fine-tuning of DNA replication and transcription is critical and potentially fragile in these cells.

Conclusions:

• MYC's control over DNA and RNA synthesis is central to its oncogenic function.
• MYC overexpression induces significant replicative and transcriptional stress.
• Therapeutic strategies aimed at inducing replicative stress are a promising avenue for treating MYC-driven tumors.